Overview: In June 2020 United Kingdom's Special Pharmaceuticals exports accounted up to £25.5M and imports accounted up to £30.5M, resulting in a negative trade balance of £4.99M. Between June 2019 and June 2020 the exports of United Kingdom's Special Pharmaceuticals have decreased by £-1.22M (-4.57%) from £26.7M to £25.5M, while imports decreased by £-28.7M (-48.5%) from £59.1M to £30.5M.
Destinations: In June 2020 Special Pharmaceuticals exported mostly to United States (£8M), France (£7.13M), Netherlands (£812k), Germany (£759k), and Denmark (£752k), and imported mostly from Hungary (£8.3M), Netherlands (£7.24M), Belgium (£4.4M), Denmark (£1.57M), and Ireland (£1.47M).
Growth: In June 2020, the decrease in Special Pharmaceuticals's year-by-year exports was explained primarily by a decrease in exports to United States (£-4.47M or -61.1%), Australia (£-1.36M or -43.8%), and Switzerland (£-832k or -66.2%). In June 2020, the decrease in Special Pharmaceuticals's year-by-year imports was explained primarily by a decrease in imports from Hungary (£-3.66M or -31.2%), Belgium (£-3.5M or -60%), and Germany (£-1.66M or -41%).